AIMS: To evaluate the impact of prophylactic octreotide on gastric emptying in patients undergoing pancreaticoduodenectomy. Postoperative pancreatic fistula (POPF) and delayed gastric emptying (DGE) are common complications after pancreaticoduodenectomy. Whereas several prospective randomized trials propose the prophylactic use of octreotide to prevent pancreatic fistula formation, somatostatin has, however, been associated with delayed gastric emptying after partial duodenopancreatectomy. METHODS: In this prospective, randomized, double-blinded, placebo-controlled trial we analyzed the influence of prophylactic octreotide on delayed gastric empting after pancreaticoduodenectomy. Patients were randomized to the placebo group (n=32) and the ...
BACKGROUND: Somatostatin analogues (SA) are currently used to prevent postoperative pancreatic fistu...
AbstractA best evidence topic was written according to a structured protocol. The question addressed...
Objectives Post-operative pancreatic fistula (POPF) is a feared complication after a pancreaticoduod...
Background: Postoperative pancreatic fistula (postoperative pancreatic fistula [POPF]) is the most c...
Background: The aim of the study was to evaluate the influence of low dose perioperative Octreotide ...
Summary: Background: Octreotide is known to decrease the rate of postoperative complication after p...
An Italian prospective multicentre study evaluated the efficacy of octreotide, a synthetic somatosta...
AbstractBackgroundOctreotide is generally administered based on the surgeon's interpretation of perc...
Background. A prospective, randomized controlled clinical trial was conducted in 33 Italian surgical...
An Italian prospective multicentre study evaluated the efficacy of octreotide, a synthetic somatosta...
Background Although the mortality rate of pancreatoduodenectomy has fallen sharply over the last two...
The aim of the present study was to evaluate the influence of low-dose perioperative octreotide on t...
International audienceBackground: Pancreatic fistula (PF), i. e., a failure of the pancreatic anasto...
AbstractBackgroundMost accrued evidence regarding prophylactic octreotide for a pancreatoduodenectom...
BACKGROUND: Somatostatin analogues (SA) are currently used to prevent postoperative pancreatic fistu...
AbstractA best evidence topic was written according to a structured protocol. The question addressed...
Objectives Post-operative pancreatic fistula (POPF) is a feared complication after a pancreaticoduod...
Background: Postoperative pancreatic fistula (postoperative pancreatic fistula [POPF]) is the most c...
Background: The aim of the study was to evaluate the influence of low dose perioperative Octreotide ...
Summary: Background: Octreotide is known to decrease the rate of postoperative complication after p...
An Italian prospective multicentre study evaluated the efficacy of octreotide, a synthetic somatosta...
AbstractBackgroundOctreotide is generally administered based on the surgeon's interpretation of perc...
Background. A prospective, randomized controlled clinical trial was conducted in 33 Italian surgical...
An Italian prospective multicentre study evaluated the efficacy of octreotide, a synthetic somatosta...
Background Although the mortality rate of pancreatoduodenectomy has fallen sharply over the last two...
The aim of the present study was to evaluate the influence of low-dose perioperative octreotide on t...
International audienceBackground: Pancreatic fistula (PF), i. e., a failure of the pancreatic anasto...
AbstractBackgroundMost accrued evidence regarding prophylactic octreotide for a pancreatoduodenectom...
BACKGROUND: Somatostatin analogues (SA) are currently used to prevent postoperative pancreatic fistu...
AbstractA best evidence topic was written according to a structured protocol. The question addressed...
Objectives Post-operative pancreatic fistula (POPF) is a feared complication after a pancreaticoduod...